Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Austin, Texas
- Most recent report
- 8-K, filed Sep 17, 2026
- Incorporated
- Delaware
- Filings on record
- 445 filings
- On EDGAR
- CIK 1829802
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 25
News 8 of 84
Prospectuses and Registrations 8 of 17
- S-3ASR Automatic shelf registration Jun 18, 2026
- S-3/A Shelf registration statement, amended Jun 10, 2026
- S-3/A Shelf registration statement, amended Jun 2, 2026
- S-8 Registration statement for an employee plan May 15, 2026
- S-3 Shelf registration statement Apr 28, 2026
- S-8 Registration statement for an employee plan Mar 28, 2025
- S-8 Registration statement for an employee plan Feb 29, 2024
- 424B5 Prospectus supplement for an offering Aug 17, 2023
Proxies 8 of 16
- DEFA14A Extra proxy material May 22, 2026
- DEFA14A Extra proxy material May 21, 2026
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- PRE 14A Preliminary proxy statement Apr 16, 2026
- DEFA14A Extra proxy material Apr 11, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2025
- PRE 14A Preliminary proxy statement Apr 1, 2025
Ownership 8 of 277
- 4 Insider reported a trade Sep 15, 2026
- 3 Insider reported their initial holding Sep 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 144 Notice of a proposed sale of restricted stock Aug 11, 2026
- 3 Insider reported their initial holding Jul 28, 2026
Other 8 of 26
- EFFECT Notice that a registration became effective Jun 12, 2026
- ARS Annual report sent to shareholders Apr 27, 2026
- D Mar 4, 2026
- ARS Annual report sent to shareholders Apr 11, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- ARS Annual report sent to shareholders Jun 15, 2023
- 8-A12B Registration of a security for exchange listing Mar 7, 2023
- EFFECT Notice that a registration became effective May 9, 2022
Everything here comes from Faeth Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.